Evidence map›Paper›PMID 34832681›Full record

ArticlePathogens (Basel, Switzerland)2021

Colistin Induces Resistance through Biofilm Formation, via Increased

Na-Hye Park, Seung-Jin Lee, Eon-Bee Lee, Biruk Tesfaye Birhanu, Seung-Chun Park

Open access · goldAbstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 4 citations in OpenAlex.

  1. Colistin Resistance in Bacteria: Current Updates on Mechanism of Action and Combating Strategies.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2026
    Review
  2. Review
  3. The use of combination therapy for the improvement of colistin activity against bacterial biofilm.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024
    Review
  4. Article
  5. Article
  6. Colistin Resistance and Management of Drug Resistant Infections.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Na-Hye ParkLaboratory Animal Center, Daegu Gyeongbuk Medical Innovation Foundation, Daegu 41061, Korea.
Seung-Jin LeeReproductive and Developmental Toxicology Research Group, Korea Institute of Toxicology, Daejeon 34114, Korea.ORCID 0000-0001-7109-6423
Eon-Bee LeeLaboratory of Veterinary Pharmacokinetics and Pharmacodynamics, College of Veterinary Medicine, Kyungpook National University, Daegu 41566, Korea.ORCID 0000-0002-8668-4508
Biruk Tesfaye BirhanuLaboratory of Veterinary Pharmacokinetics and Pharmacodynamics, College of Veterinary Medicine, Kyungpook National University, Daegu 41566, Korea.ORCID 0000-0002-5261-8406
Seung-Chun ParkLaboratory of Veterinary Pharmacokinetics and Pharmacodynamics, College of Veterinary Medicine, Kyungpook National University, Daegu 41566, Korea.ORCID 0000-0001-8539-1087
Kyungpook National University · KRDaegu-Gyeongbuk Medical Innovation Foundation · KRKorea Institute of Toxicology · KR

Funding

National Research Foundation of Korea 2019R1A2C2006277
6 · The paper itself

Abstract

This study aimed to optimize the colistin-based antibacterial therapy to prevent antimicrobial resistance related to biofilm formation in avian pathogenic

Indexed as

antibacterial therapyantibiotic resistanceAvian Pathogenic Escherichia coli (APEC)biofilm formationcolistin

Identifiers

PMID34832681
PMCPMC8620993
OpenAlexW3216378782

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.